, Tracking Stock Market Picks
Enter Symbol:
Geron Corporation (GERN) [hlAlert]

up 14.07 %

Geron Corporation (GERN) rated Buy with price target $4 by Stifel Nicolaus

Posted on: Thursday,  Aug 30, 2012  8:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Geron Corporation (NASDAQ: GERN) on 08/30/2012, when the stock price was $2.70. Since
then, Geron Corporation has gained 14.07% as of 01/25/2016's recent price of $3.08.
If you would have followed this Stifel Nicolaus's recommendation on GERN, you would have gained 14.07% of your investment in 1243 days.

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/30/2012 8:25 AM Buy
2.70 4.00
as of 12/31/2012
1 Week down  -7.23 %
1 Month   
3 Months down  -17.54 %
1 YTD down  -47.77 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy